Skip to main content

Table 1 Clinicopathological data of the gallbladder carcinoma cohort with complete clinicopathological data and correlation to the MSI status (n = 69)

From: Low frequency of mismatch repair deficiency in gallbladder cancer

All GBC patients

 

Number (percent

Number (percent)

Number (percent)

total

non-MSI

MSI

69 (100.0)

68 (98.6)

1 (1.4)

Age a

  < 69.8 yrs

28 (40.6)

27 (39.1)

1 (1.4)

  > 69.8 yrs

41 (59.4)

41 (59.4)

0 (0.0)

Sex

m

21 (30.4)

21 (30.4)

0 (0.0)

w

48 (69.6)

47 (68.1)

1 (1.4)

pT

T1

5 (7.2)

5 (7.2)

0 (0.0)

T2

30 (43.5)

29 (42.0)

1 (1.4)

T3

26 (37.7)

26 (37.7)

0 (0.0)

T4

8 (11.6)

8 (11.6)

0 (0.0)

pN

N0

13 (18.8)

13 (18.8)

0 (0.0)

N1

19 (27.5)

18 (26.1)

1 (1.4)

Nx

37 (53.6)

37 (53.6)

0 (0.0)

M

M0

56 (81.2)

55 (79.7)

1 (1.4)

M1

13 (18.8)

13 (18.8)

0 (0.0)

UICCb

UICC 2

5 (7.2)

5 (7.2)

0 (0.0)

UICC 3

18 (26.1)

17 (24.6)

1 (1.4)

UICC 4

18 (26.1)

18 (26.1)

0 (0.0)

NA

28 (40.6)

28 (40.6)

0 (0.0)

G

G1

4 (5.8)

4 (5.8)

0 (0.0)

G2

41 (59.4)

40 (58.0)

1 (1.4)

G3

24 (34.8)

24 (34.8)

0 (0.0)

L

L0

42 (60.9)

42 (60.9)

0 (0.0)

L1

27 (39.1)

26 (37.7)

1 (1.4)

V

   

V0

53 (76.8)

52 (75.4)

1 (1.4)

V1

16 (23.2)

16 (23.2)

0 (0.0)

Pn

 

Pn0

50 (72.5)

50 (72.5)

0 (0.0)

Pn1

19 (27.5)

18 (26.1)

1 (1.4)

Histology

ductal

48 (69.6)

47 (68.1)

1 (1.4)

papillary

6 (8.7)

6 (8.7)

0 (0.0)

mucinous

8 (11.6)

8 (11.6)

0 (0.0)

intestinal

1 (1.4)

1 (1.4)

0 (0.0)

other

6 (8.7)

6 (8.7)

0 (0.0)

  1. aMedian patients’ age was 71.4 years and mean age was 69.8 years; bCases with pNx had no lymph nodes resected, therefore, UICC status could not be assessed
  2. pT Pathology-based tumor stage, pN Pathology-based nodal status, M Distant metastasis status, UICC Tumor stage, G Tumor grade, L Lymph vessel invasion, V Blood vessel invasion, Pn Perineural invasion. The 6 tumors listed in the histology section as „other “are 3 adenosquamous carcinomas, 2 signet ring carcinomas, and 1 clear-cell adenocarcinoma